Across TCGA pan-cancer cohorts, ZBTB7C mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated ZBTB7C data layer compared with 27 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher ZBTB7C mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZBTB7C expression acts as an unfavorable survival marker.

HNSC are the cancer types where ZBTB7C mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	All	0.505	0.861	.008	4	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: ZBTB7C tumor-vs-normal RNA expression · all ZBTB7C data types